AI Summary
✦ ClarthaChandra Bhagat Pharma Ltd is a company operating in an unspecified business, with no disclosed segments or revenue-driving products. No recent developments are reported, leaving growth and margin catalysts unidentified. Financial disclosure is insufficient to assess revenue growth, profitability, ROE, leverage, or earnings quality. Valuation is indeterminate because P/E data is unavailable; investors must await segment reporting, operating metrics, and balance-sheet details.
Valuation Metrics
Trading 22.7% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.67). Confidence: 56%.
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
21.04
Current
12.43
Overvalued
25.06
Undervalued
10.77
5Y Average
11.83
Current
6.99
Overvalued
15.75
Undervalued
7.90
5Y Average
0.55
Current
0.33
Overvalued
0.63
Undervalued
0.47
Peers & Comparison
No sector data available for this company.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹91 CrMar 2026Latest net profit
₹3.00 CrMar 2026Latest EPS
₹3.45Mar 2026Net margin
2.4%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 22 | 48 | 43 | 51 | 44 | 75 | 119 | 102 | 65 | 22 | 26 | 91 |
| Expenses + | 21 | 47 | 42 | 50 | 43 | 74 | 124 | 104 | 66 | 22 | 24 | 89 |
| Operating Profit | 2 | 2 | 2 | 1 | 1 | 2 | -5 | -2 | -1 | -0 | 2 | 2 |
| OPM % | 7% | 3.4% | 3.8% | 2.1% | 2.3% | 2.4% | -4.2% | -2.0% | -1.8% | -1.2% | 7% | 2.4% |
| Other Income + | 0 | 0 | 0 | 1 | 1 | 0 | 7 | 4 | 3 | 2 | 0 | 3 |
| Interest | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Profit before tax | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 |
| Tax % | 25% | 33% | 24% | 31% | 31% | 15% | 32% | 34% | -11% | 69% | 22% | 26% |
| Net Profit + | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 3 |
| EPS in Rs | 0.04 | 0.21 | 0.57 | 0.48 | 0.49 | 0.72 | 0.83 | 1.19 | 0.90 | 0.23 | 0.60 | 3.45 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).